Literature DB >> 11958242

Uterine rupture and dehiscence: ten-year review and case-control study.

Sumac D Diaz1, Jacob E Jones, Michael Seryakov, William J Mann.   

Abstract

BACKGROUND: Previous cesarean section, oxytocin administration, and fetal macrosomia increase the risk of uterine rupture or dehiscence (URD).
METHODS: All 25,718 deliveries at Riverside Regional Medical Center from January 1990 to June 2000 were reviewed to describe complications and identify risk factors for URD.
RESULTS: Eleven uterine ruptures and 10 dehiscences occurred during this period (0.08%). One maternal death (5%) and three neonatal deaths (14%) occurred. Other complications included intrapartum nonreassuring fetal status (67%), 5-minute Apgar score < 7 (52%), maternal blood transfusion (24%), neonatal hypoxic injury (14%), hysterectomy (14%), and endometritis (10%). Uterine rupture/dehiscence was independently associated with fetal weight > or = 4,000 g, nonreassuring fetal status, use of oxytocin, and previous cesarean delivery; internal fetal monitoring reduced the risk of URD.
CONCLUSIONS: To reduce the risk of URD, a delivery plan should include assessment of cesarean history and fetal macrosomia,judicious use of oxytocin, and intrapartum monitoring for nonreassuring fetal status.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958242

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  9 in total

1.  Transvaginal ultrasound assessment of uterine scar after previous caesarean section: comparison with 3T-magnetic resonance diffusion tensor imaging.

Authors:  Federica Fiocchi; Elisabetta Petrella; Luca Nocetti; Serena Currà; Guido Ligabue; Tiziana Costi; Pietro Torricelli; Fabio Facchinetti
Journal:  Radiol Med       Date:  2014-08-07       Impact factor: 3.469

2.  The tip of the iceberg: Post caesarean wound dehiscence presenting as abdominal wound sepsis.

Authors:  Kaundinya Kiran Bharatam; P K Sivaraja; N J Abineshwar; Vasundhara Thiagarajan; D A Thiagarajan; Sudeep Bodduluri; K B Sriraman; A Vasantha Ragavan; Shanmuga Priya
Journal:  Int J Surg Case Rep       Date:  2015-02-11

3.  Laparoscopic correction of the uterine muscle loss in the scar after a Caesarean section delivery.

Authors:  Michał Ciebiera; Grzegorz Jakiel; Aneta Słabuszewska-Jóźwiak
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2013-12-18       Impact factor: 1.195

4.  Laparoscopic isthmocele treatment - single center experience.

Authors:  Michał Ciebiera; Magdalena Ciebiera; Magdalena Czekańska-Rawska; Grzegorz Jakiel
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-03-03       Impact factor: 1.195

5.  Post-Caesarean section niche-related impaired fertility: hypothetical mechanisms.

Authors:  Jolijn Vissers; Wouter Hehenkamp; Cornelis Bavo Lambalk; Judith Anna Huirne
Journal:  Hum Reprod       Date:  2020-07-01       Impact factor: 6.918

6.  Intrauterine negative-pressure therapy (IU-NPT) to treat peritonitis after caesarean section.

Authors:  Chris-Henrik Wulfert; Christian Theodor Müller; Ahmed Farouk Abdel-Kawi; Wolfgang Schulze; Henning Schmidt-Seithe; Sonko Borstelmann; Gunnar Loske
Journal:  Innov Surg Sci       Date:  2020-10-01

7.  Why do niches develop in Caesarean uterine scars? Hypotheses on the aetiology of niche development.

Authors:  A J M W Vervoort; L B Uittenbogaard; W J K Hehenkamp; H A M Brölmann; B W J Mol; J A F Huirne
Journal:  Hum Reprod       Date:  2015-09-25       Impact factor: 6.918

8.  Reduced pregnancy and live birth rates after in vitro fertilization in women with previous Caesarean section: a retrospective cohort study.

Authors:  J Vissers; T C Sluckin; C C Repelaer van Driel-Delprat; R Schats; C J M Groot; C B Lambalk; J W R Twisk; J A F Huirne
Journal:  Hum Reprod       Date:  2020-03-27       Impact factor: 6.918

9.  Safety and feasibility of trial of labor in pregnant women with cesarean scar diverticulum.

Authors:  Xiuqiong Zheng; Jianying Yan; Zhaozhen Liu; Xuechun Wang; Rongli Xu; Liying Li; Zhi Lin; Lianghui Zheng; Min Liu; Yan Chen
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.